Don’t Need Pershing Square: A Backdoor to Ackman Bets
Investors can gain exposure to Bill Ackman’s top stocks without buying Pershing Square. A trio of ETFs offers a cost-...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesInvestors can gain exposure to Bill Ackman’s top stocks without buying Pershing Square. A trio of ETFs offers a cost-...
A new breed of daily-reset covered-call ETFs aims to preserve more upside while delivering monthly income. Here’s how...
As market conditions shift in 2026, investors are weighing cheaper covered call ETFs against XYLD. Four funds stand o...
A nation that stays forever young isn’t about youth alone—it’s about mindset. This article translates timeless quotes...
Tesla trades around $370 as investors await Q2 2026 results, balancing a mature auto business with a growing software...
XOVR, the $1.5 billion ETF that blends pre-IPO SpaceX exposure with public-growth stocks, is drawing renewed scrutiny...
Japan’s first female prime signals a bold pivot toward U.S. cooperation on rare earths and economic security, a move ...
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
Anthropic's $200 million DoD contract is under scrutiny after reports about Claude's deployment in a January raid. Th...
HUD agencies are weighing the next steps for HECM and HMBS after an extended public-comment period, with lenders urgi...
NVIDIA is set to report after the close as investors weigh Amazon’s $200 billion 2026 capex plan. The move reframes r...
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...